Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics
-
Published:2018-10-25
Issue:12
Volume:56
Page:855-867
-
ISSN:1225-8873
-
Container-title:Journal of Microbiology
-
language:en
-
Short-container-title:J Microbiol.
Author:
Cho Min Seok,Kim Sang Yeol,Suk Ki Tae,Kim Byung-Yong
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference120 articles.
1. Abdelmalek, M.F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R.J., Diehl, A.M., and Nonalcoholic Steatohepatitis Clinical Research Network. 2010. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961–1971. 2. Alisi, A., Bedogni, G., Baviera, G., Giorgio, V., Porro, E., Paris, C., Giammaria, P., Reali, L., Anania, F., and Nobili, V. 2014. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 39, 1276–1285. 3. Aller, R., De Luis, D.A., Izaola, O., Conde, R., Gonzalez Sagrado, M., Primo, D., De La Fuente, B., and Gonzalez, J. 2011. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: A double blind randomized clinical trial. Eur. Rev. Med. Pharmacol. Sci. 15, 1090–1095. 4. Aranha, M.M., Cortez-Pinto, H., Costa, A., da Silva, I.B., Camilo, M.E., de Moura, M.C., and Rodrigues, C.M. 2008. Bile acid levels are increased in the liver of patients with steatohepatitis. Eur. J. Gastroenterol. Hepatol. 20, 519–525. 5. Bajaj, J.S., Heuman, D.M., Hylemon, P.B., Sanyal, A.J., Puri, P., Sterling, R.K., Luketic, V., Stravitz, R.T., Siddiqui, M.S., Fuchs, M., et al. 2014. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment. Pharmacol. Ther. 39, 1113–1125.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|